SCHEMBL19205886

SCHEMBL19205886

CC(C)(C)O[Si](N=C=O)(N=C=O)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL451664 0.71 TSHR (0.32)
SCHEMBL10927676 0.67
SCHEMBL1493029 0.65
SCHEMBL10612935 0.65
SCHEMBL10667864 0.63 TSHR (0.30)
SCHEMBL11212291 0.62
SCHEMBL4971423 0.59 TSHR (0.32)
SCHEMBL8072914 0.59 TSHR (0.32)
SCHEMBL575408 0.59 TSHR (0.32)
SCHEMBL2920738 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3180373-B1 BIOMATERIAL WITH REDUCED INFLAMMATORY RESPONSE GOVERNING COUNCIL UNIV TORONTO (CA) 2021-04-07 EP claimed
EP-4702059-A1 N-CADHERIN TARGETING CHIMERIC PEPTIDES FOR INHIBITING RESTENOSIS The Governing Council of the University of Toronto (CA) 2026-03-04 EP disclosed
WO-2024221109-A1 N-CADHERIN TARGETING CHIMERIC PEPTIDES FOR INHIBITING RESTENOSIS THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2024-10-31 WO disclosed
US-10973950-B2 Biomaterial with reduced inflammatory response THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2021-04-13 US disclosed
EP-3180373-B1 BIOMATERIAL WITH REDUCED INFLAMMATORY RESPONSE GOVERNING COUNCIL UNIV TORONTO (CA) 2021-04-07 EP disclosed
US-20170232142-A1 Biomaterial with Reduced Inflammatory Response THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2017-08-17 US disclosed